Ph.D John Woock - 01 Sep 2021 Form 4 Insider Report for Axonics, Inc.

Role: Chief Marketing Officer
Signature: /s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
Issuer symbol: N/A
Transactions as of: 01 Sep 2021
Net transactions value: -$740,442
Form type: 4
Filing time: 03 Sep 2021, 18:52:53 UTC
Previous filing: 19 Aug 2021
Next filing: 17 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXNX	Common Stock	Options Exercise	$8,150	+5,000	+17%	$1.63^*	34,932	01 Sep 2021	Direct
transaction	AXNX	Common Stock	Sale	$630,915	-8,443	-24%	$74.73	26,489	01 Sep 2021	Direct	F1, F2
transaction	AXNX	Common Stock	Sale	$117,677	-1,557	-5.9%	$75.58	24,932	02 Sep 2021	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXNX	Stock Option (Right to Buy)	Options Exercise	$0	-3,443	-21%	$0.000000	12,757	01 Sep 2021	Common Stock	3,443	$1.63	Direct	F4
transaction	AXNX	Stock Option (Right to Buy)	Options Exercise	$0	-1,557	-12%	$0.000000	11,200	02 Sep 2021	Common Stock	1,557	$1.63	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 15, 2021.
F2	This transaction was executed in multiple trades at prices ranging from $73.82 to $75.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $75.00 to $76.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.